当前位置：
X-MOL 学术
›
Expert Rev. Clin. Immunol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Upadacitinib for the treatment of adult patients with active psoriatic arthritis
Expert Review of Clinical Immunology ( IF 4.4 ) Pub Date : 2023-12-28 , DOI: 10.1080/1744666x.2023.2299732 Antonio Marchesoni 1, 2 , Giorgia Citriniti 1 , Nicolò Girolimetto 1 , Niccolò Possemato 1 , Carlo Salvarani 1, 3
Expert Review of Clinical Immunology ( IF 4.4 ) Pub Date : 2023-12-28 , DOI: 10.1080/1744666x.2023.2299732 Antonio Marchesoni 1, 2 , Giorgia Citriniti 1 , Nicolò Girolimetto 1 , Niccolò Possemato 1 , Carlo Salvarani 1, 3
Affiliation
Psoriatic arthritis (PsA) is a rheumatic disorder that may be responsible for relevant articular impairment. The recently licensed Janus Kinase (JaK) inhibitors represent a new opportunity to impro...
中文翻译：
乌帕替尼用于治疗活动性银屑病关节炎成年患者
银屑病关节炎 (PsA) 是一种风湿性疾病，可能导致相关关节损伤。最近获得许可的 Janus 激酶 (JaK) 抑制剂代表了改善...的新机会。
更新日期：2023-12-28
中文翻译：
乌帕替尼用于治疗活动性银屑病关节炎成年患者
银屑病关节炎 (PsA) 是一种风湿性疾病，可能导致相关关节损伤。最近获得许可的 Janus 激酶 (JaK) 抑制剂代表了改善...的新机会。
京公网安备 11010802027423号